Get the Stockscreener App
8.20
33.50%
-4.13
After Hours:
8.02
-0.18
-2.20%
Cyclacel Pharmaceuticals Inc Stock (CYCC) Forecast
The Cyclacel Pharmaceuticals Inc (CYCC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.6553, representing a -43.23% decrease from the current price of $8.20. The highest analyst price target is $4.5646, and the lowest is $4.7459.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CYCC Price Target
Average 2.7571
(-66.38% Downside)
Is Cyclacel Pharmaceuticals Inc (CYCC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 66.86 | Neutral |
| STOCH(9,6) | 75.93 | Neutral |
| STOCHRSI(14) | 65.88 | Neutral |
| MACD(12,26) | 1.5788 | Buy |
| ADX(14) | 50.52 | Buy |
| William %R | -58.05 | Neutral |
| CCI(14) | 170.28 | Buy |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.2894
Buy
|
5.0981
Buy
|
| MA20 |
2.3156
Buy
|
3.452
Buy
|
| MA50 |
2.1236
Buy
|
2.6866
Buy
|
| MA100 |
3.2985
Buy
|
3.6401
Buy
|
| MA200 |
5.7948
Buy
|
8.186
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CYCC could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 0 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on CYCC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 66.86 indicates that CYCC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 75.93 indicates that CYCC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 65.88 indicates that CYCC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 50.52 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 170.28 indicates that CYCC is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CYCC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cyclacel Pharmaceuticals Inc financial reports and earnings history, Cyclacel Pharmaceuticals Inc (CYCC) stock could reach $11.00 by 2030, $11.91 by 2040 and $27.81 by 2050. See the projected annual prices until 2050 of the Cyclacel Pharmaceuticals Inc stock below:
- Cyclacel Pharmaceuticals Inc (CYCC) is expected to reach an average price of $5.7348 in 2035, with a high prediction of $5.7309 and a low estimate of $5.6338. This indicates an $-30.06% rise from the last recorded price of $8.20.
- Cyclacel Pharmaceuticals Inc (CYCC) stock is projected to chart a bullish course in 2040, with an average price target of $11.64, representing an $41.96% surge from its current level. The forecast ranges from a conservative $11.69 to a sky-high $11.91.
- Our analysts predict Cyclacel Pharmaceuticals Inc (CYCC) to jump 133.86% by 2045, soaring from $19.19 to an average price of $19.18, potentially reaching $19.19. While $19.19 is the low estimate, the potential upside is significant.
- Cyclacel Pharmaceuticals Inc (CYCC) stock is expected to climb by 2050, reaching an average of $27.66, a $237.35% jump from its current level. However, a wide range of estimates exists, with high and low targets of $27.81 and $27.87, respectively, highlighting the market's uncertainty.
Cyclacel Pharmaceuticals Inc Stock (CYCC) Year by Year Forecast
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2025
Cyclacel Pharmaceuticals Inc Stock (CYCC) is expected to reach an average price of $4.8063 in 2025, with a high prediction of $9.6094 and a low estimate of $0.0031. This indicates an -41.39% fall from the last recorded price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $4.7646 | $4.7459 | $4.5646 | -41.89% |
| September, 2025 | $4.3297 | $4.3847 | $4.5934 | -47.20% |
| October, 2025 | $5.6386 | $4.8173 | $5.0748 | -31.24% |
| November, 2025 | $5.1487 | $5.3487 | $5.4224 | -37.21% |
| December, 2025 | $5.3826 | $4.885 | $5.0475 | -34.36% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2026
The predicted value for Cyclacel Pharmaceuticals Inc (CYCC) in 2026 is set at an average of $2.6558. Estimates vary from a peak of $5.2199 to a trough of $0.0917, indicating an -67.61% surge from the present price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.6677 | $5.0977 | $5.2199 | -43.08% |
| February, 2026 | $4.1528 | $4.3228 | $4.4964 | -49.36% |
| March, 2026 | $0.9179 | $0.7891 | $1.5021 | -88.81% |
| April, 2026 | $0.3983 | $0.0917 | $3.277 | -95.14% |
| May, 2026 | $0.4032 | $0.5568 | $0.9632 | -95.08% |
| June, 2026 | $0.4619 | $0.7332 | $0.5344 | -94.37% |
| July, 2026 | $0.9158 | $0.9283 | $0.8258 | -88.83% |
| August, 2026 | $0.5609 | $0.7134 | $0.3509 | -93.16% |
| September, 2026 | $1.6248 | $1.3714 | $1.5648 | -80.19% |
| October, 2026 | $2.1899 | $2.2935 | $2.0099 | -73.29% |
| November, 2026 | $1.735 | $1.965 | $2.1474 | -78.84% |
| December, 2026 | $1.7388 | $1.5925 | $1.4813 | -78.79% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cyclacel Pharmaceuticals Inc (CYCC) is $3.0625, with a high forecast of $4.4898 and a low forecast of $1.6352. This indicates an -62.65% decrease from the last price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8339 | $1.6352 | $1.5076 | -77.63% |
| February, 2027 | $2.559 | $1.9215 | $1.899 | -68.79% |
| March, 2027 | $3.2329 | $3.0133 | $2.9229 | -60.57% |
| April, 2027 | $2.868 | $2.8692 | $2.668 | -65.02% |
| May, 2027 | $3.1131 | $3.2431 | $3.1443 | -62.04% |
| June, 2027 | $2.707 | $3.0106 | $2.8582 | -66.99% |
| July, 2027 | $3.0321 | $3.052 | $2.8545 | -63.02% |
| August, 2027 | $4.0072 | $2.9731 | $3.8572 | -51.13% |
| September, 2027 | $4.591 | $4.1059 | $4.3123 | -44.01% |
| October, 2027 | $4.3761 | $4.5573 | $4.4898 | -46.63% |
| November, 2027 | $4.3812 | $4.3449 | $4.4224 | -46.57% |
| December, 2027 | $3.8451 | $4.2151 | $4.26 | -53.11% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2028
In 2028, Cyclacel Pharmaceuticals Inc (CYCC) is projected to reach an average price of $3.5633, with a high projection of $3.9429 and a low estimate of $3.1837. This indicates an -56.54% fall from the last price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.5802 | $3.7202 | $3.5814 | -56.34% |
| February, 2028 | $3.6853 | $3.629 | $3.6604 | -55.06% |
| March, 2028 | $3.5992 | $3.6092 | $3.7428 | -56.11% |
| April, 2028 | $4.0283 | $3.7867 | $3.901 | -50.87% |
| May, 2028 | $3.9743 | $4.0196 | $3.9429 | -51.53% |
| June, 2028 | $3.6032 | $3.6732 | $3.9269 | -56.06% |
| July, 2028 | $3.4284 | $3.4935 | $3.5808 | -58.19% |
| August, 2028 | $3.6492 | $3.4171 | $3.5103 | -55.50% |
| September, 2028 | $3.5844 | $3.6073 | $3.5907 | -56.29% |
| October, 2028 | $3.5323 | $3.5235 | $3.5161 | -56.92% |
| November, 2028 | $3.2463 | $3.2661 | $3.4307 | -60.41% |
| December, 2028 | $3.1822 | $3.1837 | $3.176 | -61.19% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2029
The 2029 price forecast for Cyclacel Pharmaceuticals Inc Stock (CYCC) is $3.9312 on average, with a high prediction of $7.856 and a low estimate of $0.00646. This represents an -52.06% decrease from the previous price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.9462 | $3.0032 | $3.1134 | -64.07% |
| February, 2029 | $3.1163 | $3.014 | $2.9576 | -62.00% |
| March, 2029 | $3.0405 | $3.0379 | $3.0254 | -62.92% |
| April, 2029 | $2.6165 | $2.8704 | $2.9942 | -68.09% |
| May, 2029 | $2.5434 | $2.5494 | $2.5291 | -68.98% |
| June, 2029 | $2.6896 | $2.7075 | $2.7089 | -67.20% |
| July, 2029 | $0.1646 | $0.2645 | $2.6202 | -97.99% |
| August, 2029 | $0.4384 | $0.5621 | $0.8779 | -94.65% |
| September, 2029 | $0.0965 | $0.00646 | $0.5265 | -98.82% |
| October, 2029 | $0.2094 | $0.00901 | $0.5601 | -97.45% |
| November, 2029 | $0.4925 | $0.335 | $0.1826 | -93.99% |
| December, 2029 | $8.678 | $0.2888 | $7.856 | +5.83% |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Price Forecast for 2030
Cyclacel Pharmaceuticals Inc Stock (CYCC) is expected to reach an average price of $9.8786 in 2030, with a high forecast of $13.67 and a low forecast of $6.0875. This signifies an +20.47% surge from the last price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.70 | $9.3935 | $11.00 | +42.73% |
| February, 2030 | $9.6999 | $11.49 | $11.13 | +18.29% |
| March, 2030 | $10.48 | $11.24 | $10.37 | +27.86% |
| April, 2030 | $13.80 | $11.38 | $12.60 | +68.25% |
| May, 2030 | $13.28 | $13.64 | $13.08 | +61.98% |
| June, 2030 | $14.23 | $13.97 | $13.36 | +73.56% |
| July, 2030 | $10.52 | $12.92 | $13.67 | +28.29% |
| August, 2030 | $9.9362 | $8.9326 | $9.6775 | +21.17% |
| September, 2030 | $1.8424 | $7.2204 | $9.0657 | -77.53% |
| October, 2030 | $5.1081 | $6.0875 | $4.9081 | -37.71% |
| November, 2030 | $10.36 | $6.2457 | $8.1783 | +26.32% |
| December, 2030 | $12.41 | $12.07 | $11.71 | +51.30% |
3.40%
2.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):